Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pharmadrug Inc C.PHRX

Alternate Symbol(s):  LMLLF

Medical Care Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural... see more

Recent & Breaking News (CSE:PHRX)

PharmaDrug's Super Smart Launches Slim MycoWeRx Brand of Functional Mushrooms

Newsfile September 23, 2021

Biotech Veteran David Kideckel Joins the Board of PharmaDrug

Newsfile August 30, 2021

PharmaDrug (CSE:PHRX) announces clinical research collaboration with The Johns Hopkins University

Julia Kennedy  August 25, 2021

PharmaDrug Announces Clinical Research Collaboration with The Johns Hopkins University to Evaluate DMT in a Comparative Clinical Study

Newsfile August 25, 2021

PharmaDrug (CSE:PHRX) appoints auditor

Brieanna McCutcheon  August 6, 2021

PharmaDrug Announces Appointment of Auditor

Newsfile August 6, 2021

PharmaDrug (CSE:PHRX) forms research collaboration with Terasaki Institute

Brieanna McCutcheon  August 5, 2021

PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease

Newsfile August 5, 2021

Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers

Newsfile July 28, 2021

CSE Bulletin: Symbol Change - Pharmadrug Inc. (BUZZ)

Newsfile July 26, 2021

PharmaDrug (CSE:BUZZ) announces stock ticker symbol change

Simon Druker  July 23, 2021

PharmaDrug Announces Stock Ticker Symbol Change to (CSE: PHRX)

Newsfile July 23, 2021

PharmaDrug (CSE:BUZZ) encouraged by preclinical cancer treatment study

Trevor Abes  July 14, 2021

PharmaDrug Reports Positive Preclinical Study Results of Cepharanthine to Treat Cancers

Newsfile July 14, 2021

PharmaDrug Announces Change of Auditor

Newsfile July 12, 2021

PharmaDrug (CSE:BUZZ) to develop antiviral pill for the treatment of COVID-19

Julia Kennedy  June 22, 2021

PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Infectious Diseases Including COVID-19

Newsfile June 22, 2021

PharmaDrug (CSE:BUZZ) launches online psilocybin retail platform in the Netherlands

Julia Kennedy  June 7, 2021

Pharmadrug's Supersmart Launches Psilocybin Online Retail Platform in the Netherlands

Newsfile June 7, 2021

Super Smart by PharmaDrug (CSE:BUZZ) launches online retail platform

Julia Kennedy  May 17, 2021